P A Rejto - JoVE Visualize

Showing results (11-20 of 14) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 14 results.

Journal of Computer-Aided Molecular Design|December 29, 2000

Deciphering common failures in molecular docking of ligand-protein complexesG M Verkhivker, D Bouzida, D K Gehlhaar, et al.

Journal of Molecular Recognition : JMR|December 28, 1999

Towards understanding the mechanisms of molecular recognition by computer simulations of ligand-protein interactionsG M Verkhivker, P A Rejto, D Bouzida, et al.

Proteins|December 18, 2001

Hierarchy of simulation models in predicting molecular recognition mechanisms from the binding energy landscapes: structural analysis of the peptide complexes with SH2 domainsG M Verkhivker, D Bouzida, D K Gehlhaar, et al.

Journal of Medicinal Chemistry|April 10, 1999

Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine replacementsP S Dragovich, T J Prins, R Zhou, et al.

Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 14 results.

Journal of Computer-Aided Molecular Design|December 29, 2000

Deciphering common failures in molecular docking of ligand-protein complexesG M Verkhivker, D Bouzida, D K Gehlhaar, et al.

Journal of Molecular Recognition : JMR|December 28, 1999

Towards understanding the mechanisms of molecular recognition by computer simulations of ligand-protein interactionsG M Verkhivker, P A Rejto, D Bouzida, et al.

Proteins|December 18, 2001

Hierarchy of simulation models in predicting molecular recognition mechanisms from the binding energy landscapes: structural analysis of the peptide complexes with SH2 domainsG M Verkhivker, D Bouzida, D K Gehlhaar, et al.

Journal of Medicinal Chemistry|April 10, 1999

Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine replacementsP S Dragovich, T J Prins, R Zhou, et al.

Pageof 2